on IKONISYS (EPA:ALIKO)
Ikonisys: New international patent for Hospitex
Ikonisys SA announces that Hospitalex International has obtained an international patent for the BLOCKfast cytoinclusion kit. This device, used for the treatment of cells in histology, stands out for its efficiency and innovation compared to traditional methods. Already well established in the Italian market, BLOCKfast shows promising growth globally.
The kit is produced in Florence with advanced chemical processes and rigorous quality controls. Obtaining this international patent, previously marked “in progress”, now allows wider distribution and accessibility of innovative solutions in cancer diagnosis.
This advancement is significant for Hospitex, underscoring its commitment to developing high-performance diagnostic solutions for cancer, with many more patents planned for the future.
R. E.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all IKONISYS news